Evaluation of Three Different Antalgic Blocks in Total Knee Prosthesis

Study acronym: Analgesia PTG
StatusRecruiting
PhaseNot applicable
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Lead sponsor: I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio to I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio Show 9 more changesShow less
    • Primary completion date: Oct 23, 2025 to Feb 23, 2027
    • Start date: Feb 6, 2025 to Aug 6, 2026
    • Sponsor refiled this as recruiting (was completed)
    • Enrollment target: 141 to 142
    • Study sites: 1 to 2
    • Study completion date: May 10, 2026 to Mar 10, 2027
    • Eligibility criteria expanded, about 6 words
    • Secondary endpoints: details revised at 1 of 1 entry
    • Study description revised
  2. Primary completion date: Jan 23, 2025 to Oct 23, 2025
    • Start date: May 6, 2024 to Feb 6, 2025
    • Study completion date: Sep 10, 2025 to May 10, 2026
    • Interventions: Levobupivacaine plus mepivacaine (Drug) to Levobupivacaine (Drug)
    v2
  3. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
This randomised trial examines the three main anaesthetic blocks used in knee replacement surgery, comparing them in terms of analgesic efficacy (primary outcome), range of motion and degree of flexion in the immediate post-operative period. Other outcomes include medication use and an analysis of any differences based on sex and age.
Trial Details
NCT Number NCT07751653
Lead Sponsor I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio
Conditions
(from sponsor)		 Analgesia
Related terms Agnosia
Enrollment 142 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov